Troy A. Ignelzi, Chief Financial Officer at Karuna Therapeutics, Inc. (KRTX), sold 10,000 shares at $116.16 ($1.2M) on 2021-09-08, disclosed to the SEC on 2021-09-10.
Open-market sale of $1.2M KRTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.16 | 7,000 | $813K | 69.3% |
| 2 | $121.01 | 600 | $73K | 6.2% |
| 3 | $120.05 | 500 | $60K | 5.1% |
| 4 | $120.05 | 1,900 | $228K | 19.4% |
| Total | $117.38 avg | 10,000 | $1.2M | 100% |
| Filing → |
| KRTX | SELL | 2023-05-25 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-02-23 | $1.1M | — | Filing → |
| KRTX | SELL | 2023-01-19 | $369K | — | Filing → |